PRIME MEDICINE INC

Prime Medicine trades -1.63 percent lower on Tuesday 27th of October

Prime Medicine stock dips 1.6% as investors weigh 52‑week highs and gene‑editing prospects—see current price, market cap, and peer comparison.

PRIME MEDICINE INC
United States
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Jake Connors

27/10/2026, 10:16

2 minutes to read

Prime Medicine is trading -1.61 percent lower with a volume of USD 16.7 mn on Monday 26th of October

Prime Medicine (PRME) stocks slipped 1.6% today, trading near $3.61 with a $665.7 M cap; learn how its gene‑editing biotech could reshape disease treatment.

PRIME MEDICINE INC
United States
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Vanessa Liu

26/10/2026, 21:19

2 minutes to read